Cambridge Epigenetix
Leading the epigenomics revolution through groundbreaking research tools
Cambridge Epigenetix has raised €24M across 2 funding rounds from 5 investors, most recently a Series B round in Mar 2016. Based in Cambridge, UK; founded 2012; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€24M
€23,658,266
Funding rounds
2
Investors
5
distinct backers
Active since
2014-10
latest 2016-03
Funding by year
EUR raised per yearCambridge Epigenetix — funding by year — interactive chart.
Data table
| Cambridge Epigenetix — funding by year | |
|---|---|
| 2014 | €4.4M |
| 2016 | €19M |
Signals
High confidenceRaise-next likelihood11
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
Exit likelihood8
base rate 11% (2+ rounds)
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2016-03-01 | Series B | €19M | GV (Google Ventures),New Science Ventures,Sequoia Capital,Syncona Partners | View deal → |
| 2014-10-01 | Series A | €4.4M | Cambridge Enterprise,New Science Ventures,Syncona Partners | View deal → |